Electromed, Inc.: stock overview

ELMDAMEXHealthcare · Electromedical & Electrotherapeutic Apparatus

Price

$24.32

November 13, 2026Market cap $203M

DCF calculator

What Ploutos Investor adds for Electromed

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 16 fiscal years, from FY2011
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

Electromed had revenue of $76M over the last 12 months and net income of $12M, a net margin of 15.8%. Revenue grew by 15.6% a year on average over the last 5 years. At $24.32 the shares trade at a P/E of 17.1, against a median of 29.8 over the last 5 fiscal years. It holds more cash than debt, by $16M. It pays no dividend.

From its SEC filings (latest fiscal year to June 30, 2026) and the price of November 13, 2026.

Its SEC filings
Market cap
$203M
8.37M shares
P/E
17.1
Today17.1
Median29.8
Revenue, 12 months
$76M
+15.6% a year over 5 years
Net margin
15.8%
FY2025: 11.8%, above 74% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2024–FY2026 fiscal years

+16.1% a year over 2 years

  • FY2026Jun 30, 202610-K
    Revenue$74M
  • FY2025Jun 30, 202510-K
    Revenue$64M
  • FY2024Jun 30, 202410-K
    Revenue$55M

Fiscal years in figures

ELMD's revenue, profit, cash flow and dividend with each year-end price, from FY2011 to FY2023, 13 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $184M
$203M
Enterprise value 
$188M
P/E 3-year median: 25.9
17.1
EV / EBIT 
12.8
EV / Revenue 
2.5
P/B 3-year median: 4.2
3.9
FCF yield 3-year median: 6.1%
4.3%
Earnings yield 3-year median: 3.9%
5.9%

Profitability

Gross margin 
79.0%
Operating margin 
19.5%
Net margin 3-year median: 11.8%
15.8%
ROIC 
23.5%
ROIC, 5-year average 
13.0%
ROE 
24.3%

Growth

Revenue, yearly change 
+15.3%
EPS, yearly change 
+52.9%
FCF, yearly change 
-24.4%
Revenue, average a year 
+15.6%
EPS, average a year 
+36.9%

The yearly change compares FY2026 with FY2025.

Balance sheet

Cash 
$16M
Total debt 
$133.0K
Of which operating leases 
$133.0K
Net cash 
$16M
Net debt / EBITDA 
-1.0x
Interest cover 
–
Current ratio 
7.19

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
1.93%
Total returned 
1.93%
Shares, yearly change 
+0.2%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 38).

Gross margin

78.1%

Above 92% of the 161 companies in its industry, and 94% of all.

Operating margin

15.1%

Above 73% of the 186 companies in its industry, and 75% of all.

Net margin

11.8%

Above 74% of the 189 companies in its industry, and 69% of all.

ROE

16.6%

Above 84% of the 174 companies in its industry, and 79% of all.

ROA

13.7%

Above 91% of the 190 companies in its industry, and 93% of all.

Revenue growth

17.0%

Above 76% of the 186 companies in its industry, and 77% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
Electromed, Inc.
CIK
1488917
Exchange
AMEX
Industry (SIC)
3845 · Electromedical & Electrotherapeutic Apparatus
Fiscal year ends
June 30
Latest annual report
June 30, 2026
Reporting currency
USD
Shares
8.37M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

The Healthcare sectorAll companies

The full analysis

What do Electromed's filings show?

These are Electromed's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about ELMD

Didn't find what you were looking for?

Ask us
What is ELMD's market cap?

Electromed, Inc.'s market cap is $203M, at a price of $24.32 on November 13, 2026 and 8.37M shares.

What is ELMD's P/E?

ELMD's P/E is 17.1, on earnings per share of $1.38 over the last 12 months. The median over the last 5 fiscal years was 29.8.

How much revenue does ELMD have?

Electromed had revenue of $76M over the last 12 months. Over the last 5 years it changed by +15.6% a year on average.

Does ELMD pay a dividend?

No. Electromed paid no regular dividend over the last 12 months.

Where do the figures come from?

From Electromed, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.